Charming Medical Faces Nasdaq Trading Suspension Nov. 9 Unless It Appeals
PUBT · 3d ago
Share
Listen to the news
- Charming Medical received Nasdaq's October 29, 2026, delisting determination for its Nasdaq-listed securities (MCTA).
- Trading will be suspended at the November 9, 2026, open unless an appeal is requested by November 5, 2026.
- The SEC suspended trading on November 11, 2025, over potential third-party manipulation; Nasdaq subsequently halted trading.
- Nasdaq has not communicated any finding of company wrongdoing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charming Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-116108), on November 05, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending